Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 2007

View Archived Issues

Insomnia: Clinical results of drugs under active development

Natural product shows in vitro potential to prevent diabetic cataract

Recent patents impart new therapeutics for respiratory and allergic disorders

Surface Logix new ROCK-2 inhibitor reduces kidney fibrosis in vivo

Recent patents disclose novel antiinfective agents

Positive preclinical assessment for the antidiabetic compound LY-2463665

Positive results for Theravance's phase II study of TD-5108

DelSite provides update on GelVac

Plethora completes patient enrollment for phase II study of PSD-597

Abbott and Genentech collaborate on oncology compounds

Advancis reports on FDA review of phase III trial design of Keflex PULSYS

BFTP/SEP continues funding of Immunotope cancer vaccine

Ipsen enters agreement with PregLem to develop reproductive medicines

SurModics and Merck & Co. sign ophthalmic license and research collaboration

Novel therapeutic agents for cardiovascular disorders imparted in recent patents

New phase II trial evaluates SCV-07 for HCV

Vasogen receives FDA guidance on Celacade program

UK-421045 selected for preclinical evaluation as topical antiscarring agent

Dade Behring grants sublicense to Beckman Coulter on cardiac markers

Phase II program begins for sufentanil patch

Aastrom's adult stem cell trial in critical limb ischemia begins treatment

Swedish clearance for phase III trial of K-101 for onychomycosis

Randomization targets met in two phase III trials of corifollitropin alfa

New formulation of Rebif recommended for European approval

Fertility treatment Pergoveris approved in E.U.

Supplemental NDA filed for Metvixia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...